Differential lung gene expression identified Zscan2 and Bag6 as novel tissue repair players in an experimental COPD model
Open Access
- 22 August 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (8) , e0309166
Abstract
Chronic obstructive pulmonary disease is a common chronic lung disease with an ever-increasing incidence. Despite years of drug research and approvals, we are still not able to halt progress or restore normal lung function. Our previous studies have demonstrated that liver growth factor—LGF has an effect on the repair of the affected tissue in a mouse model of cigarette smoke exposure, but by what pathways it achieves this is unknown. The present study aimed to identify differentially expressed genes between emphysematous mice treated with LGF to identify potential therapeutic targets for the treatment of pulmonary emphysema. The emphysema mouse model was induced by prolonged exposure to cigarette smoke. To determine the gene expression profile of the lung in smokers treated or not with LGF, lung messenger RNA gene expression was assessed with the Agilent Array platform. We carried out differentially expressed gene analysis, functional enrichment and validated in treated mouse lung samples. The treated group significantly improved lung function (~35%) and emphysema level (~20%), consistent with our previous published studies. Microarray analysis demonstrated 290 differentially expressed genes in total (2.0-fold over or lower expressed). Injury repair-associated genes and pathways were further enhanced in the lung of LGF treated mice. The expression trends of two genes (Zscan2 and Bag6) were different in emphysematous lungs treated with LGF compared to untreated lungs. Therefore, Zscan2 and Bag6 genes could play a role in regulating inflammation and the immune response in the lung that undergoes partial lung regeneration. However, further studies are necessary to demonstrate this causal relationship.Keywords
All Related Versions
Funding Information
- Instituto de Salud Carlos III (PI13/01909)
- Instituto de Salud Carlos III (PI20/01416)
This publication has 37 references indexed in Scilit:
- A novel high throughput screen to identify candidate molecular networks that regulate spermatogenic stem cell functionsBiology of Reproduction, 2022
- Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Respiratory Medicine, 2020
- The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPDScientific Reports, 2018
- A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysemaJournal of Pharmaceutical and Biomedical Analysis, 2017
- BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysisTumor Biology, 2014
- Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patientsLung Cancer, 2014
- Bag6/Bat3/Scythe: A novel chaperone activity with diverse regulatory functions in protein biogenesis and degradationBioEssays, 2013
- Therapeutic Potential of Growth Factors in Pulmonary Emphysematous ConditionLung, 2012
- Liver Growth Factor Improves Pulmonary Fibrosis Secondary to Cadmium Administration in RatsArchivos de Bronconeumología, 2010
- Purification of a liver DNA-synthesis promoter from plasma of partially hepatectomized ratsBiochemical Journal, 1986